Cambridge Cognition Holdings PLC Block Listing Return
10 Octubre 2024 - 6:44AM
RNS Regulatory News
RNS Number : 7452H
Cambridge Cognition Holdings PLC
10 October 2024
10 October
2024
Cambridge Cognition Holdings
plc
("Cambridge Cognition", the "Company" or the
"Group")
Block Listing
Return
The Company makes the following
notification pursuant to AIM Rule 29 and Schedule Six of the AIM
Rules for Companies, regarding its existing block
listings:
|
Name of applicant:
|
Cambridge Cognition Holdings
plc
|
|
Name of scheme:
|
Share Options
|
|
Period of return:
|
From:
|
1 April 2024
|
To:
|
1 October 2024
|
|
Number and class of share(s) (amount
of stock / debt securities) originally listed and the date of
admission:
|
1,000,000 ordinary shares of £0.01
each in the Company admitted to trading on 23 March 2023
|
|
Balance of unallotted securities
under scheme(s) from previous return:
|
466,316 ordinary shares
|
|
Plus:
The amount by which the block scheme(s) has been
increased since the date of the last return (if any increase has
been applied for):
|
Nil
|
|
Less:
Number of securities issued/allotted under
scheme(s) during period:
|
Nil
|
|
Equals:
Balance under scheme(s) not yet issued/allotted at
end of period:
|
466,316 ordinary shares
|
|
|
|
|
| |
|
Name of contact:
|
Simon McKeating
|
|
Telephone number of
contact:
|
+44 (0)1223 810700
|
Enquiries:
|
Cambridge Cognition Holdings
plc
Dr Steven Powell,
Chairman
|
c/o Hudson
Sandler
|
|
Hudson Sandler (Financial PR and
IR)
Dan de Belder / Hattie
Dreyfus
|
Tel: 020 7796
4133
cog@hudsonsandler.com
|
|
Panmure Liberum Limited (NOMAD and Joint
Broker)
Will Goode / Freddy Crossley / Mark
Rogers
Rupert Dearden
|
Tel: 020 7886
2968
(Corporate
Finance)
(Corporate
Broking)
|
|
Dowgate Capital Limited (Joint
Broker)
David Poutney / Nick
Chambers
|
Tel: 020 3903
7715
|
|
|
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology
company developing digital health products to better understand,
detect and treat conditions affecting brain health. The Company's
software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients
early and improve global efficiency in pharmaceutical and
healthcare industries.
For further information
visit: https://cambridgecognition.com/
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BLREAFEEFLDLFFA
Cambridge Cognition (LSE:COG)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Cambridge Cognition (LSE:COG)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
